Rezpegaldesleukin, a Regulatory T-Cell Selective IL-2 Conjugate: Lessons Learned From Preclinical Design to Clinical Evaluation in Inflammatory Skin Diseases Including Atopic Dermatitis
Time: 12:00 pm
day: Day Two AM Non-Cell Based Approaches
Details:
- Use of the appropriate design elements and experimental models for generation and preclinical evaluation
- Using clinical development approaches to address target engagement and assess PK/PD principles
- Using clinical studies to identify the correlation between the MOA and the indication
